CLASS E SHARE PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Nexien Biopharma, Inc. • September 28th, 2018 • Pharmaceutical preparations • Delaware
Company FiledSeptember 28th, 2018 Industry JurisdictionTHIS CLASS E SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. Mountain Time on January 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (the “Warrant Shares”). The purchase price of one Warrant Share shall be equal to the Exercise Price, as defined in Section 1(b).
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • September 28th, 2018 • Nexien Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 28th, 2018 Company IndustryTHIS FIRST AMENDMENT is made and entered into this 18th day of September, 2018 (the “Effective Date) between Accu-Break Pharmaceuticals, Inc. (“Licensor”) and Intiva BioPharma Inc. (“Licensee”) (the “Amendment”)